Skip to main content
SpringerLink
Log in

Therapie immunkompetenter Patienten

Addition von Cetuximab zur Radiochemotherapie von Analkarzinomen

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. James RD et al. Lancet Oncol 2013;14(6):516–24

    Article  CAS  PubMed  Google Scholar 

  2. Garg MK et al. J Clin Oncol 2017;35(7):718–26

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gunderson LL et al. J Clin Oncol 2012;30(35):4344–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Glynne-Jones R et al. Lancet Oncol 2017;18(3):347–56

    Article  PubMed  PubMed Central  Google Scholar 

  5. Doll CM et al. Int J Radiat Oncol Biol Phys 2017;97(3):554–62

    Article  CAS  PubMed  Google Scholar 

  6. Yates A et al. Clin Oncol (R Coll Radiol) 2015;27(12):700–7

    Article  CAS  Google Scholar 

  7. Erstpubliziert in Strahlenther Onkol 2017;193(6):508-9

Literatur

  • Garg MK. Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: a Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol 2017;35(7):718–26

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Oncology and Palliative Medicine, Nordland Hospital Trust, Bodø, Norwegen

    Carsten Nieder

Authors
  1. Carsten Nieder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carsten Nieder.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nieder, C. Addition von Cetuximab zur Radiochemotherapie von Analkarzinomen. Gastro-News 5, 20–21 (2018). https://doi.org/10.1007/s15036-018-0314-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-018-0314-5

Search

Navigation